Research Articles
Beyond Memory Loss: Could an Old Drug Offer New Hope Against Alzheimer's?
Exploring riluzole, an FDA-approved ALS drug, as a potential treatment for Alzheimer's disease by targeting glutamate dysregulation.
The Blood Revolution: Decoding Alzheimer's Through a Simple Pinprick
How blood-based biomarkers are transforming Alzheimer's diagnosis and treatment with groundbreaking research from Stanford and others.
The Alzheimer's Enigma: How Cutting-Edge Experiments Are Rewriting Our Battle Plan Against Dementia
Explore the groundbreaking experimental approaches revolutionizing Alzheimer's disease research and treatment in 2025.
Mapping Alzheimer's Secrets: How MRI Reveals the Brain's Hidden Battle Against Amyloid Plaques
Discover how longitudinal MRI studies in transgenic mice are revolutionizing our understanding of beta-amyloid plaque development in Alzheimer's disease.
The Silent Sentinel: How a Novel Spinal Fluid Marker is Changing Alzheimer's Detection
Discover how Aβ−3–40, a novel cerebrospinal fluid biomarker, is revolutionizing early Alzheimer's disease detection through advanced biochemical analysis.
The Chirality Switch: How a Tiny Molecular Flip Turns Alzheimer's Peptide into a Stealth Killer
Discover how a single D-glutamate molecule transforms Aβ42 into stabilized toxic oligomers, revealing new insights into Alzheimer's disease pathology.
Beyond Memory Management: Could an ALS Drug Revolutionize Alzheimer's Treatment?
Exploring how riluzole, an ALS drug, shows promise in treating Alzheimer's disease by targeting glutamate regulation and neuroprotection.
The Invisible Saboteur: How a Tiny Typo Skewed Alzheimer's Research for Decades
How a typographical error between amyloid-beta (Aβ) and amyloid-Eszett (Aß) distorted Alzheimer's research for years, with bibliometric evidence of its impact.